Bisphosphonate related osteonecrosis of the jaw and infection with actinomyces;Osteonecrosis maxilar asociada a bisfosfonatos e infección por Actinomyces

Medicina Clinica

Volumn 139, Issue 15, 2012, Pages 676-680

  Arranz Caso, J Alberto ^a   Flores Ballester, Elena ^a   Ngo Pombe, Stephanie ^a   López Pizarro, Victor ^a   Dominguez Mompello, José Luis ^a   Restoy Lozano, Andrés ^a  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

Actinomyces; Bisphosphonate; Osteonecrosis of the jaw

Indexed keywords

ALENDRONIC ACID; AMOXICILLIN; BISPHOSPHONIC ACID DERIVATIVE; ERYTHROMYCIN; RISEDRONIC ACID; TETRACYCLINE; ZOLEDRONIC ACID;

ACTINOMYCOSIS; ARTICLE; BISPHOSPHONATE RELATED OSTEONECROSIS OF THE JAW; CANCER PATIENT; HUMAN; JAW OSTEONECORSIS; JAW OSTEONECROSIS; MAXILLOFACIAL SURGERY; MEDICAL RECORD REVIEW; OSTEOPOROSIS; OUTCOME ASSESSMENT; TREATMENT OUTCOME;

ACTINOMYCES; ACTINOMYCOSIS; AGED; AGED, 80 AND OVER; ALENDRONATE; ANTI-BACTERIAL AGENTS; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; COMBINED MODALITY THERAPY; DIPHOSPHONATES; DISEASE SUSCEPTIBILITY; ETIDRONIC ACID; FEMALE; HUMANS; IMIDAZOLES; MALE; MANDIBULAR DISEASES; MAXILLARY DISEASES; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASMS; OSTEITIS; OSTEOPOROSIS; RETROSPECTIVE STUDIES;

EID: 84870063506     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2012.05.039     Document Type: Article

References (20)

1. A. Mariotti Bisphosphonates and osteonecrosis of the jaws J Dent Educ 72 2008 919 929
2. M. Pazianas, P. Miller, W.A. Blumentals, M. Bernal, and P. Kothawala Review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics Clin Ther 29 2007 1548 1558
3. S.B. Woo, J.W. Hellstein, and J.R. Kalmar Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws Ann Intern Med 144 2006 753 761
4. T. Hansen, M. Kunkel, E. Springer, C. Walter, A. Weber, and E. Siegel Actinomycosis of the jaws - histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis Virchows Arch 451 2007 1009 1017
5. N.H. Naik, and T.A. Russo Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces Clin Infect Dis 49 2009 1729 1732
6. M.E. Sarasquete, M. González, J.F. San Miguel, and R. García-Sanz Bisphosphonate-related osteonecrosis: genetic and acquired risk factors Oral Dis 15 2009 382 387
7. T. Russo Agents of actinomycosis G. Mandell, J.E. Bennett, R. Dolin, Principles and practice of infectious diseases 7th ed. 2010 Churchill Livingstone Philadelphia 3209 3219
8. J. Bagán, J. Blade, J.M. Cozar, M. Constela, R. García Sanz, and F. Gómez Veiga Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates Med Oral Patol Oral Cir Bucal 12 2007 E336 E340
9. J. Wang, N.M. Goodger, and M.A. Pogrel Osteonecrosis of the jaws associated with cancer chemotherapy J Oral Maxillofac Surg 61 2003 1104 1107
10. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws J Oral Maxillofac Surg 65 2007 369 376
11. D.M. Black, D.C. Bauer, A.V. Schwartz, S.R. Cummings, and C.J. Rosen Continuing bisphosphonate treatment for osteoporosis - for whom and for how long? N Engl J Med 366 2012 2051 2053
12. Tawil P, Jeffcoat M. Oral bisphosphonates do not increase the odds of ONJ. International Association of Dental Research (IADR) 89th General Session and Exhibition. Abstract 901. March 17, 2011.
13. A. Badros, D. Weikel, A. Salama, O. Goloubeva, A. Schneider, and A. Rapoport Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors J Clin Oncol 24 2006 945 952
14. M.N. Polizzotto, V. Cousins, and A.P. Schwarer Bisphosphonate-associated osteonecrosis of the auditory canal Br J Haematol 132 2006 114
15. R.E. Marx, Y. Sawatari, M. Fortin, and V. Broumand Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment J Oral Maxillofac Surg 63 2005 1567 1575
16. P. Aspenberg Osteonecrosis of the jaw: what do bisphosphonates do? Expert Opin Drug Saf 5 2006 743 745
17. T.B. Dodson, N.S. Raje, P.A. Caruso, and A.E. Rosenberg Case records of the Massachusetts General Hospital: case 9-2008: a 65-year-old woman with a nonhealing ulcer of the jaw N Engl J Med 358 2008 1283 1291
18. C. Magopoulos, G. Karakinaris, Z. Telioudis, K. Vahtsevanos, I. Dimitrakopoulos, and K. Antoniadis Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals Am J Otolaryngol 28 2007 158 163
19. C.I. Ripamonti, M. Maniezzo, T. Campa, E. Fagnoni, C. Brunelli, and G. Saibene Decreased occurrence of osteonecrosis of the jaw alter implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan Ann Oncol 20 2009 137 145
20. N.M. McLeod, P.A. Brennan, and S.L. Ruggiero Bisphosphonate osteonecrosis of the jaw: a historical and contemporary review Surgeon 10 2012 36 42